Gene expression ratio as a predictive determinant of nelarabine chemosensitivity in T-lymphoblastic leukemia/lymphoma.

scientific article published on 31 August 2016

Gene expression ratio as a predictive determinant of nelarabine chemosensitivity in T-lymphoblastic leukemia/lymphoma. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/PBC.26214
P698PubMed publication ID27576612

P2093author name stringYuichi Kodama
Shunsuke Nakagawa
Yasuhiro Okamoto
Yoshifumi Kawano
Naoko Imuta
Takayuki Tanabe
Yuichi Shinkoda
Yuni Yamaki
Takuro Nishikawa
Pornpun Sripornsawan
Koichiro Kurauchi
P2860cites workGemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cellsQ29937967
Nucleoside analogues and nucleobases in cancer treatment.Q34141323
The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer.Q37821595
Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemiaQ38361473
In vitro efficacy of forodesine and nelarabine (ara-G) in pediatric leukemiaQ39512415
Induction of fetal hemoglobin and ABCB1 gene expression in 9-β-D-arabinofuranosylguanine-resistant MOLT-4 cellsQ39627035
Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cellsQ39854262
WST-1-based cell cytotoxicity assay as a substitute for MTT-based assay for rapid detection of toxigenic Bacillus species using CHO cell lineQ39991355
Investigation of the freely available easy-to-use software 'EZR' for medical statisticsQ41513106
The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemiaQ42725619
Mechanisms for T-cell selective cytotoxicity of arabinosylguanineQ44443182
Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine.Q44489089
Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology GroupQ46502896
Pharmacogenomics of cytarabine in childhood leukemia.Q53830656
Expression of deoxycytidine kinase (dCK) gene in leukemic cells in childhood: decreased expression of dCK gene in relapsed leukemia.Q54110979
P433issue2
P921main subjectnelarabineQ1216264
P304page(s)250-253
P577publication date2016-08-31
P1433published inPediatric Blood & CancerQ15754342
P1476titleGene expression ratio as a predictive determinant of nelarabine chemosensitivity in T-lymphoblastic leukemia/lymphoma.
P478volume64

Search more.